Release Date: 15/10/14 09:25 Summary: Share Purchase Plan Price Sensitive: Yes Download Document 298.42KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%